Skip to main content
Vistin Pharma logo

Vistin Pharma — Investor Relations & Filings

Ticker · VISTN ISIN · NO0010734122 LEI · 5967007LIEEXZXFQY092 OL Manufacturing
Open in API
Filings indexed 518 across all filing types
Latest filing 2026-05-20 AGM Information
Country NO Norway
Listing OL VISTN

About Vistin Pharma

https://www.vistin.com/

Vistin Pharma is a pharmaceutical company specializing in the production of Metformin Hydrochloride, an Active Pharmaceutical Ingredient (API). The company operates as a pure-play, global supplier, providing high-quality Metformin to pharmaceutical companies worldwide. In addition to the standard API, Vistin Pharma offers specialized grades such as Direct Compressible (DC) Metformin. With over 50 years of experience, the company emphasizes sustainable manufacturing from its dedicated European production facility.

Recent filings

Filing Released Lang Actions
Vistin Pharma ASA: Minutes from the annual general meeting 2026 - Attachment: Minutes from AGM Vistin Pharma ASA_20_May_2026.pdf
AGM Information Classification · 88% confidence The document is the official minutes (‘Protokoll’) from the Annual General Meeting of Vistin Pharma ASA held on May 20, 2026, detailing opening, shareholder attendance, approvals of accounts, elections, authorizations to issue and repurchase shares, auditor remuneration, and other resolutions. It is a record of materials and proceedings shared during an AGM, which corresponds to code AGM-R.
2026-05-20 Norwegian Bokmål
Vistin Pharma ASA: Minutes from the annual general meeting 2026
Report Publication Announcement Classification · 85% confidence The document is very short (298 characters) and simply announces that the minutes from the AGM are attached, without including substantive content itself. Under the “menu vs. meal” rule, it is an announcement of a report’s publication rather than the report itself. Therefore, it is classified as a Report Publication Announcement (RPA).
2026-05-20 English
Disclosure of voting rights at AGM in Vistin Pharma ASA
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an announcement disclosing the voting rights/proxies held at the company’s Annual General Meeting (AGM). It is not the AGM materials themselves nor a financial report, but specifically a voting rights announcement related to the AGM. This matches the category Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-05-20 English
Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026 - Attachment: Call for annual general meeting 20 May 2026.pdf
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a formal notice (“innkalling”) to shareholders convening the annual general meeting, detailing agenda items, resolutions up for vote, proxy instructions, and supporting governance and remuneration disclosures. This corresponds to materials sent to shareholders to provide information and request votes for meetings, matching the Proxy Solicitation & Information Statement category.
2026-04-28 English
Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026 - Attachment: Remuneration policy for salary and other remuration for executive management and board members.pdf
Remuneration Information Classification · 95% confidence The document is a detailed remuneration policy describing principles, decision-making processes, and components of compensation for the board and executive management. It aligns with regulatory requirements on executive pay and is intended for shareholder approval. This matches the “Remuneration Information (DEF 14A)” category, which covers reports detailing compensation for top executives and directors.
2026-04-28 English
Vistin Pharma ASA: Notice of Annual General Meeting 20 May 2026 - Attachment: Proposal from election committee.pdf
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a pre-AGM communication outlining proposals from the Election Committee for board and committee elections at the upcoming Annual General Meeting. It provides information to shareholders to enable and solicit their votes on these matters. This matches the definition for Proxy Solicitation & Information Statement (PSI).
2026-04-28 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.